Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lustriva is a patented dietary supplement ingredient developed by Nutrition21, specifically designed for beauty and skin health applications. It is a proprietary blend of Bonded Arginine Silicate (an arginine silicon inositol complex) and Magnesium Biotinate. This combination provides highly bioavailable forms of silicon and biotin, which work synergistically to support hair thickness and skin integrity. The magnesium biotinate component is significantly more soluble than standard D-biotin, enhancing its absorption. Arginine in the complex promotes blood flow to improve nutrient delivery to hair follicles and skin tissues. Clinical studies indicate that Lustriva can support hair growth and reduce facial wrinkles and fine lines within 3 to 12 weeks of use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lustriva.